Health and Medical Federal Grants

Showing results 951-975 of 3,893 for Health and Medical federal grants, government grants and loans. For detailed information on a Health and Medical federal grant including eligibility requirements or financial assistance, click the title.

 

NIMH Mentoring Networks for Mental Health Research Education (R25)
The over-arching goal of this NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To this end, this funding...
www.FederalGrantsWire.com/nimh-mentoring-networks-...

NIMH Short Courses for Mental Health-Related Research Education (R25)
The over-arching goal of this NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To this end, this funding...
www.FederalGrantsWire.com/nimh-short-courses-for-m...

Molecular and Cellular Substrates of Complex Brain Disorders (R21)
This Funding Opportunity Announcement (FOA) uses the R21 mechanism to encourage new research activities directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular...
www.FederalGrantsWire.com/molecular-and-cellular-s...

Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
The purpose of this initiative is to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
www.FederalGrantsWire.com/platform-delivery-techno...

Molecular and Cellular Substrates of Complex Brain Disorders (R01)
This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal...
www.FederalGrantsWire.com/molecular-and-cellular-s...

Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
The purpose of this initiative is to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
www.FederalGrantsWire.com/platform-delivery-techno...

Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54)
NIH established the Institutional Development Award (IDeA) program in 1993 to enhance biomedical research activities in states that have had historically low NIH grant funding success rates. The purpose of this Funding Opportunity Announcement (FOA)...
www.FederalGrantsWire.com/institutional-developmen...

NIDDK Central Repositories Non-renewable Sample Access (X01)
The NIDDK Central Repositories house valuable samples and data from numerous major clinical studies. This FOA allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples...
www.FederalGrantsWire.com/niddk-central-repositori...

NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism...
www.FederalGrantsWire.com/ninds-create-devices-tra...

NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and Early Feasibility Studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement...
www.FederalGrantsWire.com/ninds-create-devices-tra...

NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism...
www.FederalGrantsWire.com/ninds-create-devices-tra...

Bioreactors for Reparative Medicine (R41/R42)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Bioreactors for Reparative Medicine - SBIR Direct Phase II (R44)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Bioreactors for Reparative Medicine (R43/R44)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Arts-Based Approaches in Palliative Care for Symptom Management (R01)
The purpose of this funding opportunity announcement (FOA) is to support mechanistic clinical studies aimed at understanding the impact of arts-based approaches in palliative care for symptom management. This FOA is intended to support mechanistic...
www.FederalGrantsWire.com/arts-based-approaches-in...

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN receive funding for...
www.FederalGrantsWire.com/blueprint-neurotherapeut...

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN receive funding for...
www.FederalGrantsWire.com/blueprint-neurotherapeut...

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-develop...

NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-discove...

NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-discove...

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study...
www.FederalGrantsWire.com/ahrq-health-services-res...

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-develop...

AHRQ Health Services Research Projects (R01)
The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan...
www.FederalGrantsWire.com/ahrq-health-services-res...

High Throughput Screening (HTS) to Discover Chemical Probes (R21)
This Funding Opportunity Announcement (FOA) encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement...
www.FederalGrantsWire.com/high-throughput-screenin...

Innovative Research in Cancer Nanotechnology (IRCN) (U01)
This Funding Opportunity Announcement (FOA) invites applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is an integral...
www.FederalGrantsWire.com/innovative-research-in-c...